V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009589 | 190002777 | null | null | null | null | 2018-06-06 | OCTREOTIDE | null | null | EW EUROEWING 2012 ARM A VIDE | 100605969 |
| 190009597 | 190002781 | null | null | null | null | 2019-12-07 | CARBOPLATIN + RT | null | null | CARBOPLATIN + ETOPOSIDE | 100821079 |
| 190009601 | 190002782 | 0 | 115 | Palliative (P) | 2018-07-22 | 2018-08-10 | PAM | null | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100331644 |
| 190009602 | 190002783 | 1.72 | 138 | Curative (C) | 2016-01-22 | 2016-02-17 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101469071 |
| 190009606 | 190002785 | null | null | null | null | 2017-03-10 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100928300 |
| 190009608 | 190002786 | null | null | null | null | 2016-03-21 | PAM x 2 post-surgery (cycles 3&4) | null | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100617520 |
| 190009610 | 190002787 | 1.75 | 75.6 | Neo-adjuvant (N) | 2018-04-09 | 2018-04-09 | CISPLATIN + FLUOROURACIL | 02 | N | MAP | 100120986 |
| 190009614 | 190002788 | null | null | null | null | 2016-12-10 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100647864 |
| 190009616 | 190002789 | 1.86 | 73 | Palliative (P) | 2016-05-09 | 2016-05-14 | ECX | 02 | N | DOXORUBICIN + METHOTREXATE | 101400592 |
| 190009619 | 190002790 | 1.53 | 76.7 | Neo-adjuvant (N) | 2018-07-06 | 2018-07-17 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 100675442 |
| 190009622 | 190002792 | null | null | null | null | 2018-11-18 | null | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100545631 |
| 190009623 | 190002793 | 1.65 | null | Neo-adjuvant (N) | 2017-09-26 | 2017-10-03 | CAPECITABINE + TEMOZOLOMIDE | 01 | N | EURAMOS TRIAL | 100956502 |
| 190009625 | 190002794 | null | null | null | null | 2021-06-26 | CISPLATIN + FLUOROURACIL | null | null | BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | 101433844 |
| 190009626 | 190002795 | 1.85 | 86.5 | Palliative (P) | 2018-09-04 | 2018-09-04 | PAM | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101278097 |
| 190009629 | 190002796 | 1.74 | 77.1 | Curative (C) | 2018-05-21 | 2018-05-24 | VIDE | 02 | N | DOXORUBICIN + METHOTREXATE | 101355241 |
| 190009632 | 190002798 | 1.56 | 72 | Curative (C) | 2019-06-09 | 2019-06-26 | Cisplatin + Doxorubicin | null | N | CISPLATIN + DOXORUBICIN | 101186771 |
| 190009636 | 190002799 | 1.86 | 53.4 | Neo-adjuvant (N) | 2019-05-29 | 2019-05-29 | Dox + HD Mtx (post PAM) | 2 | null | TEMOZOLOMIDE | 100342245 |
| 190009637 | 190002800 | 1.7 | 76.5 | Palliative (P) | 2016-09-20 | 2016-09-23 | EW EuroEwing 2012 Arm A VIDE | 02 | N | EW EUROEWING 2012 ARM A VIDE | 101371034 |
| 190009650 | 190002802 | 1.77 | 81 | Palliative (P) | 2019-04-18 | 2019-04-22 | BEP 5 Day | N | N | DOXORUBICIN + HD MTX | 101732192 |
| 190009651 | 190002803 | 0 | 77.25 | Palliative (P) | null | 2016-07-29 | EOX | null | null | EW EUROEWING 2012 ARM A VIDE | 101343658 |
| 190009655 | 190002804 | 1.68 | 82 | Neo-adjuvant (N) | 2019-09-21 | 2019-09-23 | Capecitabine | 02 | N | CAV | 101178161 |
| 190009658 | 190002806 | 1.63 | 63.3 | Neo-adjuvant (N) | 2018-09-30 | 2018-10-12 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101249931 |
| 190009659 | 190002807 | null | null | null | null | 2016-02-11 | null | null | null | TRIAL | 100739599 |
| 190009668 | 190002809 | null | null | null | null | 2019-12-28 | CISPLATIN + ETOPOSIDE | null | null | EURAMOS TRIAL | 100473939 |
| 190009670 | 190002810 | 1.67 | 99.1 | Curative (C) | 2017-01-26 | 2017-01-27 | Cisplatin + Doxorubicin | 2 | N | CISPLATIN + DOXORUBICIN | 101275515 |
| 190009672 | 190002811 | null | null | null | null | 2021-01-09 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101535946 |
| 190009683 | 190002813 | null | null | null | null | 2018-01-27 | Cisplatin +Fluorouracil (3 wk) | null | null | EURO-EWING | 101823405 |
| 190009697 | 190002815 | 0 | 40 | Neo-adjuvant (N) | 2018-04-12 | 2018-04-13 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101837941 |
| 190009698 | 190002816 | 1.71 | 53.1 | null | null | 2020-02-05 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101702252 |
| 190009699 | 190002817 | null | null | null | null | 2016-04-10 | Epirubicin | null | null | NOT MATCHED | 101276424 |
| 190009704 | 190002818 | 1.63 | 16.4 | Palliative (P) | 2019-10-18 | 2019-11-08 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101489948 |
| 190009709 | 190002819 | 1.59 | 105 | null | 2017-04-16 | 2017-04-28 | EW EuroEwing 2012 Arm B VDC | N | N | EW EUROEWING 2012 ARM B VDC | 100606221 |
| 190009715 | 190002822 | 1.71 | 77.6 | Curative (C) | 2019-08-03 | 2019-08-05 | Cisplatin + Doxorubicin | 01 | N | CISPLATIN + DOXORUBICIN | 100813096 |
| 190009716 | 190002823 | 1.86 | 57.7 | Curative (C) | 2019-10-08 | 2019-10-13 | EW EuroEwing 2012 Arm B VDC | 02 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100461777 |
| 190009719 | 190002825 | 0 | 49.8 | Curative (C) | 2019-07-20 | 2019-07-20 | OST Euramos 1 Closed Trial - AP | N | N | OST AP | 101772376 |
| 190009720 | 190002826 | 1.64 | 70 | Curative (C) | 2016-12-07 | 2016-12-07 | Cisplatin + Doxorubicin | null | N | CISPLATIN + DOXORUBICIN | 101530230 |
| 190009724 | 190002827 | 0 | 44 | Curative (C) | 2019-03-02 | 2019-03-02 | EW EuroEwing 2012 Arm B VDC | N | N | EW EUROEWING 2012 ARM B VDC | 100046517 |
| 190009726 | 190002829 | null | null | null | null | 2017-05-01 | MIFAMURTIDE | null | null | CARBOPLATIN + DOCETAXEL | 100301166 |
| 190009733 | 190002831 | 1.57 | 59 | Palliative (P) | 2017-02-16 | 2017-02-21 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 101188031 |
| 190009744 | 190002833 | 1.7 | 85.8 | Curative (C) | 2016-04-04 | 2016-04-05 | EURAMOS TRIAL | null | Y | DOXORUBICIN + HD MTX | 100054242 |
| 190009745 | 190002834 | null | 78.4 | Neo-adjuvant (N) | 2017-01-07 | 2017-01-09 | EURAMOS TRIAL | 02 | N | EW EUROEWING 2012 ARM A VIDE | 101566671 |
| 190009746 | 190002835 | 1.73 | 85.6 | Neo-adjuvant (N) | 2018-01-23 | 2018-01-23 | GEMCARBO | 02 | null | EURAMOS TRIAL | 100319042 |
| 190009749 | 190002836 | 1.83 | 45.3 | Curative (C) | 2018-05-17 | 2018-05-31 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101016451 |
| 190009752 | 190002837 | null | null | null | null | 2019-10-12 | Carboplatin AUC 2 - 5 | null | null | EURAMOS TRIAL | 100133161 |
| 190009756 | 190002838 | 1.81 | 57 | null | 2018-09-16 | 2018-10-07 | Carboplatin AUC 6 - 10 | 02 | null | CETUXIMAB + RT | 100261081 |
| 190009759 | 190002839 | 1.72 | 16.8 | Curative (C) | 2019-01-08 | 2019-01-17 | Carboplatin + Liposomal Doxorubicin | 02 | Y | NOT MATCHED | 100644042 |
| 190009764 | 190002841 | null | 75.3 | null | 2017-03-19 | 2017-03-25 | Carboplatin AUC 6 - 10 | 02 | null | EW EUROEWING 2012 ARM A VIDE | 101027197 |
| 190009768 | 190002842 | null | null | null | null | 2019-03-20 | MAP | null | null | CISPLATIN + FLUOROURACIL | 101135474 |
| 190009769 | 190002843 | null | null | null | null | 2018-04-01 | Dox + HD Mtx (post PAM) | null | null | AVAPRITINIB | 101868263 |
| 190009770 | 190002844 | null | null | null | null | 2017-10-10 | Cetuximab + CISPLATIN + FLUOROURACIL | null | null | EURO-EWING | 101800305 |